St Jude Medical Inc. (STJ): Today's Featured Health Care Winner

Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.

St Jude Medical ( STJ) pushed the Health Care sector higher today making it today's featured health care winner. The sector as a whole closed the day down 0.3%. By the end of trading, St Jude Medical rose $1.25 (2.4%) to $53.64 on average volume. Throughout the day, 2,135,025 shares of St Jude Medical exchanged hands as compared to its average daily volume of 1,557,700 shares. The stock ranged in a price between $51.79-$53.80 after having opened the day at $52.16 as compared to the previous trading day's close of $52.39. Other companies within the Health Care sector that increased today were: GW Pharmaceuticals PLC ADR ( GWPH), up 93.1%, Zalicus ( ZLCS), up 23.7%, Alliance HealthCare Services ( AIQ), up 13.2% and Bacterin International Holdings ( BONE), up 11.6%.

St. Jude Medical, Inc. develops, manufactures, and distributes cardiovascular and implantable neurostimulation medical devices worldwide. It operates in two divisions, Cardiovascular and Ablation Technologies, and Implantable Electronic Systems. St Jude Medical has a market cap of $15.4 billion and is part of the health services industry. Shares are up 48.0% year to date as of the close of trading on Friday. Currently there are 11 analysts that rate St Jude Medical a buy, 2 analysts rate it a sell, and 8 rate it a hold.

TheStreet Ratings rates St Jude Medical as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, largely solid financial position with reasonable debt levels by most measures and expanding profit margins. We feel these strengths outweigh the fact that the company has had sub par growth in net income.

On the negative front, China Botanic Pharmaceutical ( CBP), down 96.4%, Achillion Pharmaceuticals ( ACHN), down 58.3%, Mast Therapeutics ( MSTX), down 40.1% and Pingtan Marine Enterprise ( PME), down 14.7% , were all laggards within the health care sector with Biogen Idec ( BIIB) being today's health care sector laggard.

For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider Health Care Select Sector SPDR ( XLV) while those bearish on the health care sector could consider ProShares Ultra Short Health Care ( RXD).

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

null

More from Markets

Dow Skids and Stocks Fall Hard as Earnings Disappoint, Caterpillar Tumbles

Dow Skids and Stocks Fall Hard as Earnings Disappoint, Caterpillar Tumbles

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Caterpillar Bulldozes Industrial Sector With Bad News on Earnings Call

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Jim Cramer: If You're Afraid of the 10-Year Yield, Go to Cash

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Eli Lilly CEO Expresses Confidence in New Rheumatoid Arthritis Drug

Video: Jim Cramer on Rising Interest Rates, Trade Worries & Caterpillar

Video: Jim Cramer on Rising Interest Rates, Trade Worries & Caterpillar